Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials

Keyphrases

• Adverse Effects 33%
• Analgesic 33%
• Analgesic Effect 33%
• Cannabinoids 100%
• Chronic Noncancer Pain 100%
• Dizziness 33%
• Health Outcomes 33%
• Inclusion Criteria 33%
• Moderate to Severe 33%
• Muscle Spasticity 33%
• Muscle Stiffness 33%
• PRISMA Guidelines 33%
• Randomized Controlled Trial 100%
• Therapeutic Potential 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 33%
• Analgesic Agent 66%
• Cancer Pain 100%
• Cannabinoid 100%
• Dizziness 33%
• Muscle Rigidity 33%
• Randomized Controlled Trial 100%
• Spasticity 33%